Schedule

The Critical Care Pharmacy Preparatory Review Course will be held Saturday and Sunday, April 25-26, 2020.

Click below for the full meeting schedule.

ACCP Spring Forum Preparatory
Review and Recertification Courses
April 25-26, 2020

Critical Care Pharmacy Preparatory Review and Recertification Course -- Shock Syndromes and Sepsis, Hepatic Failure/GI/Endocrine Emergencies, and Infectious Diseases I & II

Sunday, April 28, 2019 from 12:30 PM to 5:30 PM CDT at Academic and Research Building: First Floor, Room 111

Available for 4.75 hours of CPE credit
Activity Number: 0217-0000-19-104-L01-P

Shock Syndromes & Sepsis I: Vasodilatory and Sepsis
12:30 PM to 1:30 PM
Academic and Research Building: First Floor, Room 111

Speakers
Speaker: Seth R. Bauer, Pharm.D., FCCM, BCPS, BCCCP
Critical Care Clinical Coordinator, Cleveland Clinic, Cleveland, Ohio
View Biography
Seth R. Bauer, Pharm.D., FCCM, BCPS, BCCCP
Bauer

Learning Objectives
1. Identify critical determinants affecting oxygen delivery.
2. Distinguish between the various shock syndromes on the basis of a patient’s clinical and hemodynamic parameters.
3. Interpret hemodynamic data from monitoring devices and markers of perfusion.
4. Devise a treatment strategy for when to utilize intravenous fluids and/or vasopressors in a patient with shock.
5. Develop a treatment pathway for the care of patients with sepsis or septic shock that incorporates current evidence and the Surviving Sepsis Campaign guideline recommendations.
Shock Syndromes & Sepsis II: Hypovolemic, Critical Bleeding, and Obstructive
1:30 PM to 2:30 PM
Academic and Research Building: First Floor, Room 111

Speakers
Speaker: Mitchell J. Daley, Pharm.D., BCPS
Market Clinical Pharmacy Specialist, Critical Care Dell Seton Medical Center, University of Texas, Austin, Texas
View Biography
Mitchell J. Daley, Pharm.D., BCPS
Daley

Learning Objectives
1. Identify critical determinants affecting oxygen delivery and the physiologic response to hypovolemic and obstructive shock
2. Evaluate resuscitation strategies and endpoints in the management of hypovolemic, hemorrhagic and obstructive shock.
3. Devise a treatment strategy for pharmacotherapy adjuncts in the management of bleeding and acute coagulopathy when treating patients with hemorrhagic shock.
4. Develop a treatment pathway for the care of patients on anticoagulants and antiplatelet agents in the setting of life-threatening hemorrhage or critical bleeding that incorporates current evidence and guideline recommendations.
5. Apply risk stratification to guide the approach of pharmacologic management when treating patients with acute pulmonary embolism.
6.Develop a standardized approach for the effective and safe use of thrombolytic agents in the management of acute PE.
Hepatic Failure/GI/Endocrine Emergencies
2:30 PM to 3:15 PM
Academic and Research Building: First Floor, Room 111

Speakers
Speaker: Stephanie Bass, Pharm.D., BCCCP, BCPS
Medical ICU Clinical Specialist, Department of Pharmacy, Cleveland Clinic, Cleveland, Ohio
View Biography
Stephanie  Bass, Pharm.D., BCCCP, BCPS
Bass

Learning Objectives
1. Define acute liver failure (ALF), and describe the most common causes for its occurrence.
2. Develop a treatment strategy to help manage and reduce the complications associated with ALF.
3. Evaluate the severity of an episode of acute pan¬creatitis, and construct a plan for pharmacologic, nutritional, and surgical management.
4. Identify patients at high risk of developing fistulas postoperatively, and assess the need for pharmaco¬logic versus surgical treatment.
5. Identify risk factors and treatment options for postoperative ileus and postoperative nausea and vomiting.
6. Design a treatment plan for patients who present with an acute upper gastrointestinal bleed.
7. Differentiate between the main endocrine emergen¬cies in the intensive care unit, and be able to design a therapeutic regimen for a patient presenting with each condition.
Networking Break
3:15 PM to 3:30 PM
Academic and Research Building: Second Floor, Lobby
Browse the ACCP Bookstore, grab a beverage, and network with your fellow meeting attendees.
Infectious Diseases I
3:30 PM to 4:30 PM
Academic and Research Building: First Floor, Room 111

Speakers
Speaker: Eric W. Mueller, Pharm.D., FCCM, FCCP
Assistant Director of Clinical Pharmacy Services and Research, University of Cincinnati Medical Center, Cincinnati, Ohio; Adjunct Associate Professor of Pharmacy Practice and Administrative Sciences, University of Cincinnati, Cincinnati, Ohio
View Biography
Eric W. Mueller, Pharm.D., FCCM, FCCP
Mueller

Learning Objectives
1. Develop risk factor–based empiric antibiotic regi¬mens for patients with suspected ventilator-associated pneumonia.
2. Identify a definitive management strategy for central line–associated bloodstream infections.
3. Describe definitive and supportive care pharmaco¬therapeutic interventions for patients with severe influenza.
4. Develop empiric and definitive antimicrobial therapy plans for patients with catheter-related urinary tract infection.
5. Differentiate between location of intra-abdominal infection and respective empiric antimicrobial therapy.
6. Describe the role of antibiotic therapy in patients with acute pancreatitis.
7. Develop a definitive management strategy for critically ill patients with severe Clostridium difficile infection.
8. Recommend definitive antibiotic therapy for patients with postoperative wound infection.
9. Describe the role of pharmacotherapy in the man¬agement of severe cutaneous reactions.
Infectious Diseases II
4:30 PM to 5:30 PM
Academic and Research Building: First Floor, Room 111

Speakers
Speaker: Simon Lam, PharmD, FCCM, BCCCP
Medical ICU Clinical Specialist, Cleveland Clinic, Cleveland, Ohio
View Biography
Simon Lam, PharmD, FCCM, BCCCP
Lam

Learning Objectives
1. Compose a plan to incorporate quality metrics into pre- and postsurgical care.
2. Identify key members of an antimicrobial steward¬ship team and common strategies used by the team to optimize antibiotic use.
3. Provide empiric antibiotic therapy recommendations for critically ill patients with community-acquired or health care–associated meningitis.
4. Differentiate different microbiological rapid diag¬nostic tests and their relative advantages and disadvantages.
5. Devise an antimicrobial management strategy using procalcitonin guidance.
6. Analyze therapeutic options for the treatment of multidrug-resistant pathogens in the intensive care unit (ICU).
7. Devise an optimal treatment plan for critically ill immunocompromised patients with infectious dis¬eases.
8. Distinguish each of the commonly used antifungal agents and their places in therapy in an ICU setting.